Suchergebnisse - "Jian Wang"

PubPharm (106)

1

Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

in: Journal for ImmunoTherapy of Cancer | 2024

von Jian Wang | Wei-Lien Wang | Jiemiao Hu | +9

2

CAR T cells: engineered immune cells to treat brain cancers and beyond

in: Molecular Cancer | 2023

von Zoufang Huang | Saikat Dewanjee | Pratik Chakraborty | +6

3

A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer

in: Frontiers in Oncology | 2023

von Shuai Han | Dongjie Jiang | Feng Zhang | +6

4

A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma

in: BMC Cancer | 2023

von Lingyu Zhu | Shuo Shen | Huan Wang | +10

5

Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors

in: Cancers | 2023

von Wafik Zaky | Dristhi Ragoonanan | Izhar Batth | +7

6

Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord

in: Journal of Bone Oncology | 2023

von Qingying Liu | Zhongyuan Lu | Huan Ren | +10

7

E-cigarette awareness and use, among adult residents in Shanghai, China

in: Tobacco Induced Diseases | 2023

von Jian Wang | Chen-Chen Xie | Xiao-Xian Jia | +7

8

Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis

in: BMC Cancer | 2023

von Qiao Ke | Lei Wang | Ziguo Lin | +14

9

Solitary Celiac Lymph Node Metastasis Has a Better Long-Term Survival Compared With Solitary Mediastinal Lymph Node Metastasis in Esophagectomy of Esophageal Squamous Cell Cancer: A Propensity Score Matching Analysis

in: Frontiers in Oncology | 2022

von Kun-Kun Li | Tao Bao | Ying-Jian Wang | +4

10

Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors

in: Cell Death Discovery | 2022

von Yingzhuo Xu | Jian Wang | Xu Wang | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]